Contact this trialFirst, we need to learn more about you.
CDK4 and CDK6 inhibitor
High-Dose Abemaciclib for Early-Stage Breast Cancer
Recruiting1 awardPhase 2
Stamford, Connecticut
This trial is testing if a higher dose of abemaciclib is better tolerated than the standard dose for treating early-stage breast cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.